Randomised study of immunotherapy with OK-432 in uterine cervical carcinoma
- 31 December 1993
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (11), 1542-1546
- https://doi.org/10.1016/0959-8049(93)90291-m
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Stage IB squamous cell cancer of the cervix: Clinicopathologic features related to survivalAmerican Journal of Obstetrics and Gynecology, 1991
- Morbidity and survival patterns in patients after radical hysterectomy and postoperative adjuvant pelvic radiotherapyGynecologic Oncology, 1990
- Cytotoxic and cytostatic effects of the streptococcal preparation OK-432 and its subcellular fractions on human ovarian tumor cellsCancer, 1989
- Radical hysterectomy with pelvic lymph node dissection for treatment of cervical cancer: A clinical review of 954 casesGynecologic Oncology, 1989
- Induction of tumor growth inhibitory factor (TGIF) in human mononuclear cells by OK-432, a streptococcal preparationCancer Immunology, Immunotherapy, 1988
- Prognostic factors in stage I carcinoma of the cervixGynecologic Oncology, 1981
- Surgical and combination therapy of cancer of the cervix uteri stages Ib and IIaGynecologic Oncology, 1981
- Irradiation alone or in combination with surgery in stage ib and iia carcinoma of the uterine cervix.A nonrandomized comparisonCancer, 1979
- Radical pelvic surgery versus radiation therapy for Stage I carcinoma of the cervix (exclusive of microinvasion)American Journal of Obstetrics and Gynecology, 1976
- Studies on the Anticancer and Streptolysin S‐Forming Abilities of Hemolytic StreptococciJapanese Journal of Microbiology, 1967